Table 3 Correlation between serum p53Abs and clinicopathologic parameters, distinguishing between subjects with normal or altered LFT
From: Serum p53 antibody detection in patients with impaired lung function
| Â | Normal LFT | p-valuea | Altered LFT | p-valuea |
|---|---|---|---|---|
Age (years) | (< 58 / ≥ 58) |  | (< 58 / ≥ 58) |  |
Negative | 221/154 (59%/ 41%) | 0.233 | 87/174 (33%/67%) | 0.938 |
Positive | 15/5 (75%/25%) | Â | 4/10 (29%/71%) | Â |
Missing | 4 | Â | 1 | Â |
Gender | Male / Female | Â | Male / Female | Â |
Negative | 202/176 (53%/47%) | 0.915 | 157/105 (60%/40%) | 0.136 |
Positive | 12/9 (57%/43%) | Â | 12/2 (86%/14%) | Â |
No. of cigarettes per day | (> 20 / ≤ 20) |  | (> 20 / ≤ 20) |  |
Negative | 100/234 (30%/70%) | 0.001* | 97/122 (44%/56%) | 0.904 |
Positive | 14/7 (67%/33%) | Â | 5/7 (42%/58%) | Â |
Packs-year | (> 40 / ≤ 40) |  | (> 40 / ≤ 40) |  |
Negative | 105/229 (31%/69%) | 0.081# | 106/112 (49%/51%) | 0.720 |
Positive | 11/10 (52%/48%) | Â | 7/5 (58%/42%) | Â |